•Weight-loss interventions in gastrointestinal and liver diseases: a narrative review of GLP-1 based therapies, bariatric surgery, and endoscopic approaches
•The mechanistic insights and therapeutic potential of immunoproteasomes in inflammatory bowel disease
•IL-1 family cytokine bioactivity, not abundance, defines functional tissue states in inflammatory bowel disease
•Stem Cells and Derivatives in Inflammatory Bowel Disease: Mechanisms, Sources, and Therapeutic Perspectives
•Vaccination in Adult Patients with Inflammatory Bowel Disease: An Updated Practical Approach